By transfecting an ER− ESO+ BC line with an ER-encoding plasmid we failed to detect any significant alteration of ESO expression, suggesting that the correlation between the HR status of BC and the expression of ESO may reflect a particular molecular subtype of the tumor rather than a direct effect of HR on ESO expression. This evidence concerns the gene ESR1 and breast cancer.